Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017
April 27 2017 - 8:00AM
Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company
focused on developing and commercializing new chemical entities
designed to alleviate pain and pruritus by selectively targeting
peripheral kappa opioid receptors, today announced that the Company
will host a conference call and live audio webcast on Thursday, May
4, 2017, at 4:30 p.m. ET to report first quarter 2017 financial
results and provide a corporate update.
To participate in the conference call, please
dial 855-445-2816 (domestic) or 484-756-4300 (international) and
refer to conference ID 10052639. A live webcast of the call can be
accessed under “Events and Presentations” in the News &
Investors section of the Company’s website at
www.CaraTherapeutics.com.
An archived webcast recording will be available
on the Cara website beginning approximately two hours after the
call.
About Cara Therapeutics
Cara Therapeutics is a clinical-stage biotechnology company
focused on developing and commercializing new chemical entities
designed to alleviate pain and pruritus by selectively targeting
peripheral kappa opioid receptors. Cara Therapeutics is developing
a novel and proprietary class of product candidates that target the
body's peripheral nervous system and have demonstrated initial
efficacy in patients with moderate-to-severe pain without inducing
many of the undesirable side effects typically associated with
currently available pain therapeutics.
INVESTOR CONTACT:
Michael Schaffzin
Stern Investor Relations
212-362-1200
michael@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Sep 2023 to Sep 2024